Market Overview

Galmed Pharma (NASDAQ: GLMD)

4.17 +0.40 (10.61%)

Analyst Ratings

DateResearch FirmActionCurrentPT
11/25/20Canaccord GenuityMaintainsBuy20.0
5/22/20B. Riley FBRDowngradesNeutral8.0
5/15/20Raymond JamesMaintainsOutperform20.0
3/13/20StifelMaintainsBuy25.0
3/13/20B. Riley FBRMaintainsBuy11.0
2/04/20Craig-HallumInitiates Coverage OnBuy18.0
1/30/20Cantor FitzgeraldAssumesOverweight14.0
7/22/19Laidlaw & Co.Initiates Coverage OnBuy25.0
12/12/18B. Riley FBRInitiates Coverage OnBuy28.0
7/20/18Raymond JamesInitiates Coverage OnOutperform26.0

Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!

Sign up to receive Benzinga's Daily Ratings Newsletter